- Home
- IAE vs INCR Comparison
IAE vs INCR Comparison
Compare IAE & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAE
- INCR
- Stock Information
- Founded
- IAE 2007
- INCR 1994
- Country
- IAE United States
- INCR Israel
- Employees
- IAE N/A
- INCR N/A
- Industry
- IAE Trusts Except Educational Religious and Charitable
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- IAE Finance
- INCR Health Care
- Exchange
- IAE Nasdaq
- INCR Nasdaq
- Market Cap
- IAE 74.3M
- INCR 88.9M
- IPO Year
- IAE N/A
- INCR N/A
- Fundamental
- Price
- IAE $7.20
- INCR $1.63
- Analyst Decision
- IAE
- INCR
- Analyst Count
- IAE 0
- INCR 0
- Target Price
- IAE N/A
- INCR N/A
- AVG Volume (30 Days)
- IAE 46.3K
- INCR 32.8K
- Earning Date
- IAE 01-01-0001
- INCR 08-28-2025
- Dividend Yield
- IAE 10.21%
- INCR N/A
- EPS Growth
- IAE N/A
- INCR N/A
- EPS
- IAE N/A
- INCR N/A
- Revenue
- IAE N/A
- INCR $65,575,323.00
- Revenue This Year
- IAE N/A
- INCR $69.54
- Revenue Next Year
- IAE N/A
- INCR $41.75
- P/E Ratio
- IAE N/A
- INCR N/A
- Revenue Growth
- IAE N/A
- INCR N/A
- 52 Week Low
- IAE $5.31
- INCR $1.17
- 52 Week High
- IAE $6.45
- INCR $2.07
- Technical
- Relative Strength Index (RSI)
- IAE 55.73
- INCR 53.29
- Support Level
- IAE $7.11
- INCR $1.57
- Resistance Level
- IAE $7.24
- INCR $1.65
- Average True Range (ATR)
- IAE 0.09
- INCR 0.07
- MACD
- IAE -0.00
- INCR -0.01
- Stochastic Oscillator
- IAE 73.53
- INCR 57.50
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.